FEB 25, 2020 4:28 PM PST

China Approves Trials for Favipiravir to Treat Coronavirus

WRITTEN BY: Annie Lennon

As of February 25th 2020, there have been 80, 354 reported cases of COVID-19 (Wuhan coronavirus), including 2,707 deaths and 27,898 recoveries. Currently with no official treatment, drug companies around the world are scrambling to offer existing medicines as possible cures and treatments. Now, Chinese authorities have granted favipiravir, an experimental antiviral treatment designed for influenza, approval for clinical trials to see whether it works against coronavirus as well. 

Developed by Japan’s Fujifilm Toyama Chemical pharmaceutical company, favipiravir is an RNA-dependent RNA polymerase inhibitor that works by preventing viruses from replicating. Having shown promise in treating a wide range of viruses including other varieties of coronavirus, previous studies have shown that the drug carries a risk of teratogenicity (disturbing the development of an embryo or foetus) and embryotoxicity capable of causing congenital disabilities. Thus, until now, health authorities in Japan have granted it conditional approval- only allowing it for serious viral outbreaks such as avian influenza or Ebola virus. 

Its approval to begin trials in China however came following tests on 70 patients infected with coronavirus in Shenzhen, Guangdong province. Demonstrating an encouraging profile after treating patients with mild to adverse reactions to the virus, the drug now joins two other drugs, antimalarial drug chloroquine, and Gilead’s experimental treatment remdesivir, in addressing the coronavirus outbreak. 

Chloroquine is currently under examination in over 100 patients in more than 10 hospitals between Beijing and Guangdong province. In trials until now, doctors have reported that groups of patients taking the drug have been able to recover from feverous symptoms, have demonstrated improved computed tomography (CT) scans of lungs and have become negative in viral nucleic acid tests at a larger rate than those on parallel treatments. 

Meanwhile, the World Health Organization (WHO) has said that  remdesivir “may be the best shot for treating the coronavirus”. This comes after an American patient who contracted coronavirus recovered fully following treatment with the drug, alongside other trials demonstrating its efficacy in alleviating symptoms, and a previous study showing it to be effective in preventing the Middle East respiratory syndrome coronavirus when given prior infection. 

 

Sources: Korea Biomedical Review, Pharmaceutical Technology and CNN Business

 

About the Author
  • Annie graduated from University College London and began traveling the world. She is currently a writer with keen interests in genetics, psychology and neuroscience; her current focus on the interplay between these fields to understand how to create meaningful interactions and environments.
You May Also Like
JAN 03, 2020
Drug Discovery & Development
JAN 03, 2020
Researchers Grow Psilocybin from E. Coli Bacteria
Previously considered to be narcotic, and under tight regulation as an illicit drug for decades, research from recent years on the possible medicinal prope...
FEB 06, 2020
Drug Discovery & Development
FEB 06, 2020
China Begins Trials for Antiviral Drug to Tackle Coronavirus
So far, coronavirus has infected over 31,493 people globally, and has killed 638. Although 1,563 people have reportedly recovered, due to its fast-spreadin...
MAR 07, 2020
Drug Discovery & Development
MAR 07, 2020
Do Surgical Masks Really Prevent the Spread of COVID-19?
As COVID-19 has spread around the world, there has been a global run on surgical masks. This has led some governments, such as that in India, to ban the ex...
MAR 20, 2020
Drug Discovery & Development
MAR 20, 2020
WHO Says Ibuprofen May Still Work Against COVID-19
Since the announcement of a French Health Minister in recent days linking usage of ibuprofen and other non-steroidal anti-inflammatory medicines (NSAIDs) w...
MAR 21, 2020
Technology
MAR 21, 2020
Modeling Mutations to Beat Drug Resistance
Mutations in bacteria or even cancer cells can make them resistant to drug treatments—that means they no longer respond to it and thus continue their...
MAR 28, 2020
Drug Discovery & Development
MAR 28, 2020
Could the Blood of Coronavirus Survivors Save Lives?
As the search for a treatment for coronavirus continues, a perhaps obscure-sounding candidate has begun to make headlines: blood containing antibodies from...
Loading Comments...